CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PFIZER

PFE
$142.74B
Large Cap
NASDAQHealthcare🇺🇸North America81.0K employees

Drugs in Pipeline

640

Phase 3 Programs

381

Upcoming Catalysts

52

Next Catalyst

Feb 16, 2026

8d
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply

Market Overview

Stock performance and market intelligence

Catalyst Timeline

52 upcoming, 3 past

Phase 2Next

PG4 Phase 2 Results Expected

Feb 16, 2026PG4

Primary completion for PG4 trial (NCT06531538) in Pneumococcal Disease

Source
Phase 2

Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection Phase 2 Results Expected

Feb 17, 2026Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection900

Primary completion for Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection trial (NCT05703607) in Shingles

Source
⭐Phase 3

talazoparib plus enzalutamide Phase 3 Results Expected

Feb 18, 2026talazoparib plus enzalutamide599

Primary completion for talazoparib plus enzalutamide trial (NCT04821622) in Prostate Cancer

Source
Phase 2

carboplatin Phase 2 Results Expected

Feb 24, 2026Carboplatin352

Primary completion for carboplatin trial (NCT03485209) in Colorectal Neoplasms

Source
Phase 2

cisplatin Phase 2 Results Expected

Feb 24, 2026cisplatin352

Primary completion for cisplatin trial (NCT03485209) in Colorectal Neoplasms

Source
Phase 2

tisotumab vedotin Phase 2 Results Expected

Feb 24, 2026Tisotumab Vedotin352

Primary completion for tisotumab vedotin trial (NCT03485209) in Colorectal Neoplasms

Source
Phase 2

Abemaciclib Phase 2 Results Expected

Mar 1, 2026Abemaciclib37

Primary completion for Abemaciclib trial (NCT05548127) in Breast Cancer

Source
Phase 2

ARV-471 Phase 2 Results Expected

Mar 1, 2026ARV-47137

Primary completion for ARV-471 trial (NCT05548127) in Breast Cancer

Source
⭐Phase 3

sigvotatug vedotin Phase 3 Results Expected

Mar 12, 2026Sigvotatug Vedotin703

Primary completion for sigvotatug vedotin trial (NCT06012435) in Carcinoma, Non-Small-Cell Lung

Source
⭐Phase 3

docetaxel Phase 3 Results Expected

Mar 12, 2026Docetaxel703

Primary completion for docetaxel trial (NCT06012435) in Carcinoma, Non-Small-Cell Lung

Source
⭐Phase 3

Ritlecitinib Phase 3 Results Expected

Mar 22, 2026Ritlecitinib

Primary completion for Ritlecitinib trial (NCT05583526) in Stable Nonsegmental Vitiligo

Source
Phase 2

Exemestane Phase 2 Results Expected

Mar 31, 2026exemestane333

Primary completion for Exemestane trial (NCT06105632) in Advanced or Metastatic Breast Cancer

Source
Phase 2

Fulvestrant Phase 2 Results Expected

Mar 31, 2026fulvestrant333

Primary completion for Fulvestrant trial (NCT06105632) in Advanced or Metastatic Breast Cancer

Source
Phase 2

Tisotumab Vedotin Phase 2 Results Expected

Mar 31, 2026Tisotumab Vedotin214

Primary completion for Tisotumab Vedotin trial (NCT03786081) in Cervical Cancer

Source
Phase 2

PF-07220060 CDK4 inhibitor Phase 2 Results Expected

Mar 31, 2026PF-07220060 CDK4 inhibitor333

Primary completion for PF-07220060 CDK4 inhibitor trial (NCT06105632) in Advanced or Metastatic Breast Cancer

Source
⭐Phase 3

oxaliplatin Phase 3 Results Expected

Apr 3, 2026oxaliplatin400

Primary completion for oxaliplatin trial (NCT05253651) in Colorectal Neoplasms

Source
⭐Phase 3

cetuximab Phase 3 Results Expected

Apr 3, 2026Cetuximab400

Primary completion for cetuximab trial (NCT05253651) in Colorectal Neoplasms

Source
⭐Phase 3

tucatinib Phase 3 Results Expected

Apr 3, 2026tucatinib400

Primary completion for tucatinib trial (NCT05253651) in Colorectal Neoplasms

Source
⭐Phase 3

fluorouracil Phase 3 Results Expected

Apr 3, 2026fluorouracil400

Primary completion for fluorouracil trial (NCT05253651) in Colorectal Neoplasms

Source
Phase 2

Cetuximab Phase 2 Results Expected

Apr 12, 2026Cetuximab107

Primary completion for Cetuximab trial (NCT05217446) in Metastatic Colorectal Cancer

Source
Phase 2

Encorafenib Phase 2 Results Expected

Apr 12, 2026Encorafenib107

Primary completion for Encorafenib trial (NCT05217446) in Metastatic Colorectal Cancer

Source
⭐Phase 3

Daratumumab Phase 3 Results Expected

Apr 27, 2026Daratumumab944

Primary completion for Daratumumab trial (NCT05020236) in Multiple Myeloma

Source
⭐Phase 3

Elranatamab Phase 3 Results Expected

Apr 27, 2026Elranatamab944

Primary completion for Elranatamab trial (NCT05020236) in Multiple Myeloma

Source
Phase 2

Multivalent Pneumococcal Vaccine - Formulation 1 Phase 2 Results Expected

May 23, 2026Multivalent Pneumococcal Vaccine - Formulation 1558

Primary completion for Multivalent Pneumococcal Vaccine - Formulation 1 trial (NCT06182124) in Pneumococcal Disease

Source
Phase 2

disitamab vedotin Phase 2 Results Expected

May 31, 2026disitamab vedotin120

Primary completion for disitamab vedotin trial (NCT06003231) in Carcinoma, Non-Small-Cell Lung

Source
⭐Phase 3

cisplatin Phase 3 Results Expected

Jun 30, 2026cisplatin400

Primary completion for cisplatin trial (NCT05911295) in Urothelial Carcinoma

Source
⭐Phase 3

disitamab vedotin Phase 3 Results Expected

Jun 30, 2026disitamab vedotin400

Primary completion for disitamab vedotin trial (NCT05911295) in Urothelial Carcinoma

Source
⭐Phase 3

gemcitabine Phase 3 Results Expected

Jun 30, 2026Gemcitabine400

Primary completion for gemcitabine trial (NCT05911295) in Urothelial Carcinoma

Source
⭐Phase 3

carboplatin Phase 3 Results Expected

Jun 30, 2026Carboplatin400

Primary completion for carboplatin trial (NCT05911295) in Urothelial Carcinoma

Source
⭐Phase 3

nirmatrelvir Phase 3 Results Expected

Jul 30, 2026Nirmatrelvir160

Primary completion for nirmatrelvir trial (NCT05261139) in COVID-19

Source
⭐Phase 3

ritonavir Phase 3 Results Expected

Jul 30, 2026ritonavir160

Primary completion for ritonavir trial (NCT05261139) in COVID-19

Source
Phase 2

BAT Phase 2 Results Expected

Aug 17, 2026BAT48

Primary completion for BAT trial (NCT05639647) in Gram-negative Bacterial Infections

Source
Phase 2

ATM-AVI Phase 2 Results Expected

Aug 17, 2026ATM-AVI48

Primary completion for ATM-AVI trial (NCT05639647) in Gram-negative Bacterial Infections

Source
Phase 2

PF-07220060 + PF-07104091 combination dose escalation Phase 2 Results Expected

Aug 23, 2026PF-07220060 + PF-07104091 combination dose escalation192

Primary completion for PF-07220060 + PF-07104091 combination dose escalation trial (NCT05262400) in Breast Cancer

Source
Phase 2

PF-07868489 Phase 2 Results Expected

Sep 2, 2026PF-0786848992

Primary completion for PF-07868489 trial (NCT06137742) in Pulmonary Arterial Hypertension

Source
Phase 2

Midazolam Phase 2 Results Expected

Sep 23, 2026Midazolam362

Primary completion for Midazolam trial (NCT04557449) in Liposarcoma

Source
Phase 2

PF-07220060 Phase 2 Results Expected

Sep 23, 2026PF-07220060362

Primary completion for PF-07220060 trial (NCT04557449) in Liposarcoma

Source
⭐Phase 3

Rimegepant Phase 3 Results Expected

Oct 8, 2026Rimegepant200

Primary completion for Rimegepant trial (NCT06616194) in Migraine

Source
⭐Phase 3

Enzalutamide Phase 3 Results Expected

Dec 2, 2026Enzalutamide900

Primary completion for Enzalutamide trial (NCT06629779) in Metastatic Castration-Resistant Prostate Cancer

Source
⭐Phase 3

PF-06821497 Phase 3 Results Expected

Dec 2, 2026PF-06821497900

Primary completion for PF-06821497 trial (NCT06629779) in Metastatic Castration-Resistant Prostate Cancer

Source
⭐Phase 3

ibuzatrelvir Phase 3 Results Expected

Dec 6, 2026ibuzatrelvir2,330

Primary completion for ibuzatrelvir trial (NCT07013474) in COVID-19 Infection

Source
Phase 2

disitamab vedotin Phase 2 Results Expected

Dec 11, 2026disitamab vedotin372

Primary completion for disitamab vedotin trial (NCT04879329) in Urothelial Carcinoma

Source
Phase 2

Ritlecitinib 50 mg Phase 2 Results Expected

Dec 25, 2026Ritlecitinib 50 mg200

Primary completion for Ritlecitinib 50 mg trial (NCT07219615) in Chronic Spontaneous Urticaria

Source
Phase 2

Ribociclib Phase 2 Results Expected

Dec 30, 2026Ribociclib20

Primary completion for Ribociclib trial (NCT05573555) in Breast Cancer

Source
⭐Phase 3

ARV-471 (PF-07850327) Phase 3 Results Expected

Dec 30, 2026ARV-471 (PF-07850327)59

Primary completion for ARV-471 (PF-07850327) trial (NCT05909397) in Breast Cancer

Source
Phase 2

ARV-471 Phase 2 Results Expected

Dec 30, 2026ARV-47120

Primary completion for ARV-471 trial (NCT05573555) in Breast Cancer

Source
⭐Phase 3

Lenalidomide Phase 3 Results Expected

Dec 31, 2026Lenalidomide238

Primary completion for Lenalidomide trial (NCT04404283) in Diffuse Large B-cell Lymphoma

Source
Phase 2

Cetuximab Phase 2 Results Expected

Dec 31, 2026Cetuximab35

Primary completion for Cetuximab trial (NCT05226871) in Breast Cancer

Source
Phase 2

Palbociclib Phase 2 Results Expected

Dec 31, 2026Palbociclib35

Primary completion for Palbociclib trial (NCT05226871) in Breast Cancer

Source
Phase 2

Letrozole Phase 2 Results Expected

Dec 31, 2026Letrozole35

Primary completion for Letrozole trial (NCT05226871) in Breast Cancer

Source
Phase 2

Fulvestrant Phase 2 Results Expected

Dec 31, 2026fulvestrant35

Primary completion for Fulvestrant trial (NCT05226871) in Breast Cancer

Source
⭐Phase 3

RSVpreF Phase 3 Results Expected

Jan 9, 2027RSVpreF38,861

Primary completion for RSVpreF trial (NCT05035212) in Lower Respiratory Tract Illness

Source

AI Predictions & Institutional Flow

Machine learning insights and smart money movement

FDA Submissions

Pending NDA/BLA submissions with predicted PDUFA dates

Drug Pipeline

Clinical development programs and drug candidates

Drug Pipeline

FSME-IMMUN NEW 0.25 ml

Phase 3

Tick-borne Encephalitis

Insulin Lispro

Phase 3

Diabetes Mellitus

Bifeprunox

Phase 3

Schizophrenia

Epoetin Hospira

Phase 3

Chronic Renal Failure Requiring Hemodialysis

Sunitinib malate

Phase 3

Breast Neoplasms

Ethambutol hydrochloride

Phase 3

Mycobacterium Avium-intracellulare Infection

ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride ER)

Phase 3

Pain

ritonavir

Phase 3

COVID-19

ReFacto AF

Phase 3

Hemophilia A

binimetinib

Phase 3

MSS

ropinirole

Phase 3

Parkinson Disease

Sirolimus

Phase 3

Renal Transplantation

Desvenlafaxine Succinate Sustained-Release

Phase 3

Major Depressive Disorder

Gemcitabine

Phase 3

Pancreatic Neoplasms

Cetuximab

Phase 3

Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Ceftazidime - Avibactam ( CAZ-AVI)

Phase 3

Complicated Urinary Tract Infection

Vancomycin

Phase 3

Bacterial Infections

Dacarbazine

Phase 3

Metastatic or Unresectable Cutaneous Melanoma

Etanercept

Phase 3

Pulmonary Fibrosis

Avelumab (MSB0010718C)

Phase 3

Renal Cell Cancer

In open-label phase: treatment with tofacitinib

Phase 3

Arthritis Juvenile Idiopathic

cefuroxime plus erythromycin

Phase 3

Pneumonia

PF-05280014

Phase 3

Metastatic Breast Cancer

Quillivant Oral Suspension XR

Phase 3

Attention Deficit Hyperactivity Disorder

Prevenar 13™

Phase 3

Infections, Meningococcal

Desvenlafaxine Succinate

Phase 3

Major Depressive Disorder

Enzalutamide

Phase 3

Breast Cancer

Voriconazole

Phase 3

Neutropenia

indobufen

Phase 3

Atrial Fibrillation

Adalimumab

Phase 3

Rheumatoid Arthritis

PF-04965842 200 mg

Phase 3

Dermatitis

Methotrexate

Phase 3

Arthritis, Rheumatoid

desvenlafaxine 50 mg

Phase 3

Depressive Disorder, Major

Isovorin

Phase 3

Gastric Cancer

Nirmatrelvir

Phase 3

COVID-19

Doripenem

Phase 3

Complicated Urinary Tract Infection (cUTI) Including Acute Pyelonephritis

Midazolam

Phase 3

Sedation

Artemether-lumefantrine

Phase 3

Malaria, Falciparum

Rapamune

Phase 3

Renal Allograft Recipients

Effexor XR

Phase 3

Depression

Fesoterodine PR 4 mg

Phase 3

Urinary Bladder, Neurogenic

cisplatin

Phase 3

Carcinoma, Non-Small-Cell Lung (NSCLC)

desipramine

Phase 3

Depression

Abrocitinib 100 mg

Phase 3

Atopic Dermatitis

desvenlafaxine succinate sustained release

Phase 3

Vasomotor Symptoms

Anidulafungin, VER002

Phase 3

Aspergillosis

treatment

Phase 3

Non Squamous Lung Cancer

Tofacitinib

Phase 3

Rheumatoid Arthritis

fluorouracil

Phase 3

Colorectal Cancer

Duloxetine 60 mg/day

Phase 3

Depressive Disorder, Major

Etrasimod

Phase 3

Alopecia Areata

Elranatamab

Phase 3

Multiple Myeloma

Fenofibrate

Phase 3

Hyperlipidemia

Azithromycin SR

Phase 3

Acute Bronchitis

Disease-modifying antirheumatic drug

Phase 3

Arthritis, Rheumatoid

Ritlecitinib 100 mg

Phase 3

Vitiligo

20vPnC

Phase 3

Pneumococcal Disease

Genotonorm

Phase 3

Growth Disorders

Varenicline tartrate

Phase 3

Smoking Cessation

Irinotecan

Phase 3

Glioma

pegaptanib sodium

Phase 3

Macular Degeneration

tanezumab 5 mg

Phase 3

Arthritis

Tanezumab 2.5 mg

Phase 3

Osteoarthritis, Knee

rLP2086 vaccine

Phase 3

Meningitis, Meningococcal

Apixaban

Phase 3

Atrial Fibrillation

Azithromycin plus Chloroquine

Phase 3

Malaria

atorvastatin

Phase 3

Hypercholesterolemia, Familial

Fx-1006A

Phase 3

Familial Amyloid Polyneuropathy

Sulfadoxine-Pyrimethamine/Chloroquine

Phase 3

PLASMODIUM FALCIPARUM MALARIA

Mefloquine

Phase 3

Malaria, Falciparum

CP 690,550

Phase 3

Rheumatoid Arthritis

PN-152,243)/PN-196,444

Phase 3

Sarcoma

Bazedoxifene Acetate

Phase 3

Osteoporosis

PF-04965842 100 mg

Phase 3

Dermatitis, Atopic

gemcitabine hydrochloride

Phase 3

Lung Cancer

Sigvotatug Vedotin

Phase 3

Non-Small Cell Lung Cancer

desvenlafaxine SR

Phase 3

Depression

Standard of Care FIX Replacement therapy

Phase 3

Hemophilia B

PVC (daily for 21 days, 7 days off)

Phase 3

Atrophic Vaginitis

Dexmedetomidine HCL Injection

Phase 3

Awake Fiberoptic Intubation

Bazedoxifene/Conjugated Estrogen

Phase 3

Vaginal Atrophy

desvenlafaxine succinate sustained release tablets

Phase 3

Major Depressive Disorder

Cyclosporine

Phase 3

Kidney Transplant

Amphotericin B

Phase 3

Mycoses

Pegvisomant

Phase 3

Acromegaly

Ceftaroline

Phase 3

Community-Acquired Bacterial Pneumonia

MenACWY-TT

Phase 3

Meningococcal ACWY Disease

Tamoxifen

Phase 3

Breast Neoplasms

PF-06741086

Phase 3

Hemophilia A

Clostridium difficile vaccine

Phase 3

Clostridium Difficile Associated Disease

DVS-SR 50 mg

Phase 3

Major Depressive Disorder

Varenicline

Phase 3

Smoking

RSVpreF Vaccine

Phase 3

Respiratory Syncytial Virus

Levofloxacin

Phase 3

Community-Acquired Infections

fulvestrant

Phase 3

Uterine Neoplasms

Desvenlafaxine Sustained Release

Phase 3

Fibromyalgia

Pemetrexed

Phase 3

Carcinoma, Non-Small-Cell Lung

PF-06838435/ fidanacogene elaparvovec

Phase 3

Hemophilia B

gemtuzumab ozogamicin

Phase 3

Leukemia

13vPnC + TIV

Phase 3

Pneumococcal Infections

Zyvox® / Linezolid

Phase 3

Bacterial Infections

CP-690,550 (tofacitinib)

Phase 3

Juvenile Idiopathic Arthritis

PF-02341066

Phase 3

Carcinoma, Non-Small-Cell Lung

Antibiotic

Phase 3

Pneumonia, Pneumococcal

Sunitinib + Capecitabine

Phase 3

Breast Neoplasms

Axitinib (AG-013736)

Phase 3

Hepatocellular Carcinoma

Osivelotor

Phase 3

Sickle Cell Disease

Imatinib

Phase 3

Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive

DIC075V (intravenous diclofenac sodium)

Phase 3

Pain, Postoperative

PhXA41

Phase 3

Glaucoma

Interferon Alfa

Phase 3

Carcinoma, Renal Cell

13-valent Pneumoccocal Conjugate Vaccine

Phase 3

Pneumococcal Conjugate Vaccine

PF-08634404

Phase 3

Carcinoma, Hepatocellular

Fragmin/ Dalteparin Sodium

Phase 3

Diabetic Foot Ulcer

Temsirolimus (CCI-779)

Phase 3

Advanced Renal Cell Carcinoma

Glasdegib

Phase 3

Acute Myeloid Leukemia

Rimegepant 25 MG

Phase 3

Migraine

chemotherapy

Phase 3

Leukemia

fluoxetine

Phase 3

Major Depressive Disorder

MERREM I.V. 2g as a 3 hour infusion every 8 hours

Phase 3

Pneumonia

PF-07055480 (giroctocogene fitelparovec): Recombinant AAV2/6 Human Factor VIII Gene Therapy

Phase 3

Hemophilia A

Ertapenem

Phase 3

Bacterial Infections

Inclacumab

Phase 3

Sickle Cell Disease

Daratumumab

Phase 3

Multiple Myeloma

Dazukibart

Phase 3

Dermatomyositis

Docetaxel

Phase 3

Carcinoma, Non-Small-Cell Lung

Azithromycin microspheres 2.0 single dose

Phase 3

Community-Acquired Pneumonia

Mevrometostat

Phase 3

Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Crisaborole Ointment

Phase 3

Atopic Dermatitis

Vanquix Auto-Injector (Diazepam Injection)

Phase 3

Seizures

Dexmedetomidine hydrochloride

Phase 3

Sedation

Rimegepant/BHV3000

Phase 3

Pediatric Migraine

PF-06438179

Phase 3

Rheumatoid Arthritis

Fentanyl

Phase 3

Anesthesia

Irinotecan + 5 FU + folinic acid

Phase 3

Colorectal Neoplasms

NSAID

Phase 3

Chronic Pain

Ritlecitinib lower dose

Phase 3

Severe Alopecia Areata

Epogen (Amgen)

Phase 3

Chronic Kidney Disease

PPSV23

Phase 3

Pneumococcal Disease

"Investigational"Auto-injector (sumatriptan succinate)

Phase 3

Migraine

VLA15

Phase 3

Lyme Borreliosis

Lenalidomide

Phase 3

Multiple Myeloma

Bococizumab (PF-04950615; RN316)

Phase 3

Hyperlipidemia

23-valent Pneumococcal Polysaccharide Vaccine

Phase 3

Pneumococcal Vaccines

BeneFIX

Phase 3

Hemophilia B

Background NSAID

Phase 3

Spondylitis, Ankylosing

VFEND® I.V., Oral

Phase 3

Candidiasis

DVS SR

Phase 3

Depressive Disorder, Major

PF-06821497

Phase 3

Metastatic Castrate Resistant Prostate Cancer (mCRPC)

Ribociclib

Phase 3

Breast Cancer

CP-945,598

Phase 3

Obesity

Ibuprofen 400 mg caplet

Phase 3

Patient Compliance

cabergoline

Phase 3

Restless Legs Syndrome

voriconazole (Vfend)

Phase 3

Candidiasis

Acetaminophen

Phase 3

Pain

Ceftriaxone sodium

Phase 3

Intra-abdominal Infections

Bazedoxifene Acetate (TSE-424)

Phase 3

Osteoporosis

Bococizumab 150mg

Phase 3

Hyperlipidemia

topotecan

Phase 3

Cervical Cancer

PF-08046054

Phase 3

Non-small Cell Carcinoma

Dupilumab

Phase 3

Dermatitis

CP-690, 550

Phase 3

Psoriasis

Rimegepant 75mg Orally Disintegrating Tablets (ODT)

Phase 3

Acute Migraine

CAZ-AVI

Phase 3

Complicated Intra-Abdominal Infection

Milnacipran

Phase 3

Depression

naproxen

Phase 3

Osteoarthritis

Ibuprofen 250 mg

Phase 3

Post-surgical Pain Following Extraction of Molar Teeth

Temsirolimus

Phase 3

Renal Cell Carcinoma

20-valent pneumococcal conjugate vaccine (20vPnC)

Phase 3

Pneumococcal Disease

Unfractionated Heparin (UFH)

Phase 3

Deep Vein Thrombosis

tolterodine tartrate

Phase 3

Overactive Bladder

Pertuzumab

Phase 3

HER2 Positive Breast Cancer

exemestane (Aromasin)

Phase 3

Breast Neoplasms

Tetanus and diphtheria toxoids and acellular pertussis (Tdap) vaccine

Phase 3

Alopecia Areata

23-valent Pneumococcal Polysaccharide Vaccine (23vPS)

Phase 3

HIV Infections

Anidulafungin

Phase 3

Neutropenia

adenosine

Phase 3

Coronary Artery Disease

Dexamethasone

Phase 3

Multiple Myeloma

Varenicline Tartarate

Phase 3

Smoking Cessation

Abrocitinib 200 mg

Phase 3

Dermatitis, Atopic

Placebp

Phase 3

Respiratory Syncytial Virus

Treatment with Genotropin in different dosages

Phase 3

Growth Disorder

prinomastat

Phase 3

Brain and Central Nervous System Tumors

MEK162

Phase 3

Metastatic Colorectal Cancer

Tofacitinib 5 mg BID

Phase 3

Psoriatic Arthritis

Abrocitinib

Phase 3

Atopic Dermatitis

5 fluorouracil

Phase 3

Metastatic Colorectal Cancer

LGX818

Phase 3

Solid Tumors Harboring a BRAF V600 Mutation

vemurafenib

Phase 3

Melanoma

Genotonorm (Somatropin)

Phase 3

Fetal Growth Retardation

pantoprazole for approximately 9 weeks.

Phase 3

Gastroesophageal Reflux

RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE

Phase 3

Respiratory Syncytial Virus (RSV)

SU011248

Phase 3

Gastrointestinal Stromal Tumors

Pantoprazole for approximately 9 weeks

Phase 3

Gastroesophageal Reflux

pantoprazole sodium enteric-coated spheroid

Phase 3

Gastroesophageal Reflux

Seasonal Inactivated Influenza Vaccine

Phase 3

Respiratory Syncytial Virus

Investigator's choice

Phase 3

Lymphoma

azithromycin (Zithromax)

Phase 3

Pharyngitis

IV Diclofenac

Phase 3

Postoperative Pain

(PN-152,243)/PN-196,444

Phase 3

Neoplasms

Morphine

Phase 3

Sedation

Sirolimus (Rapamune®)

Phase 3

Renal Transplant

oxaliplatin

Phase 3

Colorectal Neoplasms

Epogen Amgen

Phase 3

Chronic Renal Failure

Fesoterodine PR 8 mg

Phase 3

Urinary Bladder, Neurogenic

mycophenolate mofetil

Phase 3

Graft vs Host Disease

azithromycin sustained release

Phase 3

Pneumonia

ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)

Phase 3

Osteoarthritis

leucovorin

Phase 3

Colorectal Carcinoma

azithromycin SR (Zithromax; compound: CP-62,993)

Phase 3

Maxillary Sinusitis

clarithromycin extended release (ER)

Phase 3

Pneumonia

Xiapex

Phase 3

Dupuytren's Contracture

MTZ

Phase 3

Complicated Intra-abdominal Infection

anastrozole

Phase 3

Breast Neoplasms

Standard of Care

Phase 3

Macular Edema Associated With Diabetes Mellitus

vaccine-13vPnC

Phase 3

Pneumococcal Infections

PF-04965842

Phase 3

Atopic Dermatitis

ATM-AVI

Phase 3

Complicated Intra-Abdominal Infections, cIAIs

Recombinant Coagulation Factor IX (BeneFIX)

Phase 3

Hemophilia B

Ibuprofen 250 mg / Acetaminophen 500 mg

Phase 3

Fever

Celecoxib

Phase 3

Schizophrenia

Formaldehyde inactivated, sucrose gradient purified TBE virus antigen, strain Neudörfl

Phase 3

Encephalitis, Tick-Borne

Amlodipine

Phase 3

Hypertension

Topical IBU twice daily

Phase 3

Ankle Injuries

Clostridium difficile

Phase 3

Clostridium Difficile Associated Disease

UFT

Phase 3

Colon Cancer

5-FU

Phase 3

Neoplasms

Leuprolide Open Label

Phase 3

Hormone Sensitive Prostate Cancer

MabThera®

Phase 3

Follicular Lymphoma

MenACWY-CRM

Phase 3

Meningococcal Vaccine

DA-9501

Phase 3

Sedation

paclitaxel

Phase 3

Breast Neoplasms

rLP2086

Phase 3

Healthy

Investigational Medical Product (IMP) administered in parent study

Phase 3

Osteoarthritis

VENLAFAXINE

Phase 3

Panic Disorders

PF-05280586

Phase 3

Rheumatoid Arthritis

Quadrivalent influenza modRNA vaccine

Phase 3

Influenza, Human

ibuzatrelvir

Phase 3

COVID-19 Infection

Inotuzumab ozogamicin

Phase 3

ACUTE LYMPHOBLASTIC LEUKEMIA

7vPnC

Phase 3

Vaccines, Pneumococcal

FLAG (fludarabine, cytarabine and G-CSF)

Phase 3

Acute Lymphoblastic Leukemia

MenABCWY

Phase 3

Meningococcal Vaccine

Multivalent Group B streptococcus vaccine

Phase 3

Group B Streptococcus Infections

Infanrix hexa

Phase 3

Healthy

C.difficile vaccine

Phase 3

Clostridioides Difficile Associated Disease

Celebrex

Phase 3

Osteoarthritis,Knee

Abemaciclib

Phase 3

Breast Cancer

propiverine

Phase 3

Urinary Bladder, Overactive

ATRA plus 6-MP and MTX

Phase 3

Leukemia, Myelocytic, Acute

Sirolimus (RAPAMUNE)

Phase 3

Graft vs Host Disease

Meningococcal group C polysaccharide conjugate vaccine

Phase 3

Neisseria Meningitidis

Donepezil (Aricept)

Phase 3

Alzheimer Disease

Moxifloxacin

Phase 3

Chronic Bronchitis

binodenoson

Phase 3

Coronary Artery Disease

Itraconazole

Phase 3

Antifungal Prophylaxis of Invasive Fungal Infections

bivalent rLP2086

Phase 3

Meningococcal Infection

Inhaled human insulin

Phase 3

Diabetes Mellitus, Type 1

Temozolomide

Phase 3

Glioblastoma

Hib

Phase 3

Pneumococcal Infections

Avelumab

Phase 3

Urothelial Cancer

DVS-233 SR (desvenlafaxine sustained release )

Phase 3

Major Depressive Disorder

bazedoxifene 20 mg/ conjugated estrogens 0.45 mg

Phase 3

Menopause

Amoxicillin/clavulinic acid

Phase 3

Bronchitis, Chronic

desvenlafaxine succinate (DVS) SR

Phase 3

Vasomotor Symptoms

PF-06823859

Phase 3

Myositis

Ritlecitinib

Phase 3

Stable Nonsegmental Vitiligo

Nonacog alfa

Phase 3

Hemophilia B

Novel Ibuprofen

Phase 3

Pain

AG-013736

Phase 3

Carcinoma, Pancreatic Ductal

Epoetin Hospira Arm

Phase 3

Chronic Kidney Disease (CKD)

Azithromycin/Chloroquine

Phase 3

Malaria, Falciparum

Imipenem

Phase 3

Bacterial Pneumonia

marstacimab

Phase 3

Hemophilia A

Sunitinib

Phase 3

Neuroendocrine Tumors

Bosutinib

Phase 3

Polycystic Kidney, Autosomal Dominant

Inhaled Insulin

Phase 3

Asthma

Rimegepant

Phase 3

Acute Migraine

Bazedoxifene/Conjugate Estrogens (CE)

Phase 3

Endometrial Hyperplasia

7-valent Pneumococcal Conjugate Vaccine

Phase 3

Pneumococcal Infection

Modified Bolus 5-FU/LV with Irinotecan

Phase 3

Colorectal Neoplasms

varenicline (CP-526,555)

Phase 3

Smoking Cessation

Tigecycline

Phase 3

Gram-Positive Bacterial Infections

fesoterodine fumarate

Phase 3

Overactive Bladder

amoxicillin

Phase 3

Tonsillitis

SPM 907

Phase 3

Overactive Bladder Syndrome

Somatropin

Phase 3

Endocrine System Diseases

Parecoxib Sodium/Valdecoxib

Phase 3

Pain

Palbociclib

Phase 3

Breast Cancer

Pregabalin

Phase 3

Epilepsy, Partial

amoxicillin/clavulanate postassium (Augmentin ES-600)

Phase 3

Acute Otitis Media

DVS-233

Phase 3

Menopause

Tisotumab Vedotin

Phase 3

Cervical Cancer

13-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Vaccines

Sorafenib

Phase 3

Renal Cell Carcinoma

levonorgestrel/ethinyl estradiol

Phase 3

Menstruation Disturbances

Ritlecitinib higher dose

Phase 3

Severe Alopecia Areata

PF-07321332

Phase 3

COVID-19

AN2690 Topical Solution, 5%

Phase 3

Onychomycosis of Toenails

AN2728 Topical Ointment, 2%

Phase 3

Dermatitis, Atopic

Pentavac

Phase 3

Vaccines, Pneumococcal

Encorafenib

Phase 3

BRAF V600E-mutant Metastatic Colorectal Cancer

20-valent pneumococcal conjugate vaccine

Phase 3

Pneumococcal Disease

Talazoparib with enzalutamide

Phase 3

mCRPC

Group C Meningococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine (GCMP-TT)

Phase 3

Meningitis, Meningococcal

Letrozole

Phase 3

Breast Neoplasms

Genotropin

Phase 3

Idiopathic Short Stature

oxycodone HCl and naltrexone HCl extended-release capsules

Phase 3

Chronic Noncancer Pain

Zavegepant

Phase 3

Migraine

pantoprazole

Phase 3

Gastroesophageal Reflux

[S,S]-Reboxetine

Phase 3

Fibromyalgia

PF-06651600

Phase 3

Active Non-segmental Vitiligo

Taliglucerase alfa

Phase 3

Gaucher Disease

fluconazole

Phase 3

Tinea Capitis

PF-06410293

Phase 3

Rheumatoid Arthritis

linezolid

Phase 3

Febrile Neutropenia

Group C Meningococcal Polysaccharide-Tetansu Toxoid Conjugate (MenC-TT) vaccine and 7-valent Pneumococcal CRM197-conjugate vaccine (PCV7)

Phase 3

Neisseria Meningitidis (Bacterial Meningitis)

Desvenlafaxine succinate sustained-release (DVS SR)

Phase 3

Depression

Epirubicin with Cyclophosphamide, followed by a Taxane

Phase 3

Adenocarcinoma

Ceftazidime-avibactam

Phase 3

Complicated Intra-abdominal Infection

talazoparib plus enzalutamide

Phase 3

Prostate Cancer

Ibuprofen/Caffeine

Phase 3

Pain

PF-06947386

Phase 3

Complicated Intra-abdominal Infection

tucatinib

Phase 3

HER2-positive Breast Cancer

CP-690,550

Phase 3

Crohn's Disease

Tick-Borne Encephalitis (TBE) Vaccine (Inactivated)

Phase 3

Encephalitis, Tick-borne

Bococizumab (PF-04950615;RN316)

Phase 3

Hyperlipidemia

Azithromycin

Phase 3

Community Acquired Pneumonia (CAP)

ponsegromab

Phase 3

Non-small Cell Lung Cancer

Dexmedetomidine

Phase 3

Sedation

DVS-233 SR

Phase 3

Major Depressive Disorder

Dacomitinib (PF-00299804)

Phase 3

Non-Small Cell Lung Cancer

Genotropin (PN-180,307) Somatropin

Phase 3

Infant, Small for Gestational Age

exemestane

Phase 3

Breast Neoplasms

Erlotinib

Phase 3

Non-small Cell Lung Cancer

sumanirole

Phase 3

Parkinson Disease

UK-390,957

Phase 3

Ejaculation

torcetrapib/atorvastatin

Phase 3

Hyperlipidemia

RSVpreF

Phase 3

RSV Infection

disitamab vedotin

Phase 3

Urothelial Carcinoma

Fesoterodine

Phase 3

Overactive Bladder Syndrome

Nimenrix

Phase 3

Meningococcal Vaccine

7-Valent Pneumococcal Conjugate Vaccine (7vPnC)

Phase 3

Healthy Subjects

Meningococcal vaccine GSK134612

Phase 3

Infections, Meningococcal

13-valent pneumococcal conjugate vaccine (13vPnC)

Phase 3

Healthy Subjects

Moroctocog alfa (AF-CC)

Phase 3

Hemophilia A

lecozotan SR (SRA-333)

Phase 3

Alzheimer Disease

tanezumab 10 mg

Phase 3

Osteoarthritis

Desvenlafaxine Succinate Sustained-Release 10mg

Phase 3

Major Depressive Disorder

olmesartan alone or in combination with hydrochlorothiazide

Phase 3

Essential Hypertension

7 valent pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

Inhaled human insulin (EXUBERA™)

Phase 3

Diabetes Mellitus, Type 2

Tolterodine ER

Phase 3

Overactive Bladder

Fragmin

Phase 3

Diabetic Foot Ulcer

Tafamidis

Phase 3

Transthyretin (TTR) Amyloid Cardiomyopathy

Interferon-alfa

Phase 3

Carcinoma, Renal Cell

tanezumab

Phase 3

Arthritis

13vPnC

Phase 3

Vaccines, Pneumococcal Conjugate Vaccine

Rifabutin

Phase 3

Mycoses

endocrine-modulating drug therapy

Phase 3

Prostate Cancer

Ibuprofen Sodium

Phase 3

Pain

ceftazidim-avibactam (CAZ-AVI, experimental product)

Phase 3

Nosocomial Pneumonia (NP)

Gefitinib

Phase 3

Non-small Cell Lung Cancer With EGFR-Activating Mutations

Carboplatin

Phase 3

Non-Small-Cell Lung Carcinoma

leflunomide

Phase 3

Prostate Cancer

Cyclosporin or tacrolimus

Phase 3

Graft Rejection

Edotecarin

Phase 3

Breast Neoplasms

Ceftaroline fosamil

Phase 3

Complicated Skin and Soft Tissue Infection

Levonorgestrel 90 mg and Ethinyl Estradiol 20 mg

Phase 3

Oral Contraceptive

Enbrel (etanercept)

Phase 3

Ankylosing Spondylitis

Zmax

Phase 3

Otitis Media

Venlafaxine ER

Phase 3

Panic Disorder

vancomycin with aztreonam

Phase 3

Skin Diseases, Infectious

ARV-471

Phase 3

Advanced Breast Cancer

ARV-471 (PF-07850327)

Phase 3

Breast Cancer

valdecoxib

Phase 3

Pain

Havrix (HAV)

Phase 3

Meningococcal Vaccine

NWP09

Phase 3

Attention Deficit Hyperactivity Disorder

PF-07220060

Phase 3

Liposarcoma

Rimegepant (PF-07899801)

Phase 3

Acute Treatment of Migraine

13 valent Pneumococcal Conjugate Vaccine

Phase 3

Pneumococcal Infections

7vPnc pneumococcal conjugate vaccine

Phase 3

Vaccines, Pneumococcal

Multivalent Pneumococcal Vaccine - Formulation 1

Phase 2

Pneumococcal Disease

Oxycodone hydrochloride (HCl) extended release (ER), opioid agonist; oral

Phase 2

Osteoarthritis of the Knee

AN2690 Solution, 5.0%

Phase 2

Onychomycosis

PF-07038124 ointment

Phase 2

Atopic Dermatitis

PF-06838435 (formerly SPK-9001)

Phase 2

Hemophilia B

axitinib

Phase 2

Carcinoma, Non-Small Cell Lung

Zithromax™ (azithromycin) 500mg tablets

Phase 2

Sinusitis

PF-06291874

Phase 2

Diabetes Mellitus, Type II

Sitexsentin sodium

Phase 2

Diastolic Heart Failure

Vascular Endothelial Growth Factor Receptor [VEGFR] and Platelet-Derived Growth Factor Receptor [PDGFR] inhibitor

Phase 2

Kidney Neoplasms

RN624

Phase 2

Neuralgia, Postherpetic

AN2728 ointment, 2%

Phase 2

Psoriasis

PF-06882961

Phase 2

Diabetes

Talazoparib

Phase 2

Prostate Cancer

PF-00489791

Phase 2

Diabetic Nephropathies

PF-04447943

Phase 2

Alzheimer's Disease

UK-453, 061

Phase 2

HIV-1

ACC-001(3µg) + QS21

Phase 2

Alzheimer Disease

PD 0332991

Phase 2

Breast Cancer

ARRY-502, CRTh2 antagonist; oral

Phase 2

Asthma

Levonorgestrel

Phase 2

Ovulation

Formulation A

Phase 2

Respiratory Tract Infections

Candidate 1: PF-07915234: VZV modRNA Powder for Suspension for Injection

Phase 2

Shingles

CPG 7909 Injection

Phase 2

Carcinoma, Melanoma

PF-07275315

Phase 2

Asthma

PF-05089771

Phase 2

Postoperative Dental Pain

Multivalent

Phase 2

Pneumococcal Infections

PD-217,014

Phase 2

Irritable Bowel Syndrome

Filibuvir

Phase 2

Hepatitis

CP-526,555 (varenicline)

Phase 2

Smoking Cessation

meningococcal B rLP2086 vaccine candidate

Phase 2

Meningitis, Meningococcal

AN2728

Phase 2

Psoriasis

PF-00610355

Phase 2

Pulmonary Disease, Chronic Obstructive

PF-00868554

Phase 2

Hepatitis C

Recombinant Human Interleukin-11 (rhIL-11)

Phase 2

Crohn Disease

Capecitabine

Phase 2

Breast Cancer

Investigational drug

Phase 2

Carcinoma, Non-Small-Cell Lung

ARRY-371797, p38 inhibitor, oral

Phase 2

LMNA-Related Dilated Cardiomyopathy

ARRY-438162, MEK inhibitor; oral

Phase 2

Rheumatoid Arthritis

ACC-001

Phase 2

Alzheimer's Disease

FOLFIRI (The combination regimen of Irinotecan, l-Leucovorin and 5-Fluorouracil)

Phase 2

Unresectable or Metastatic Colorectal Cancer

SU011248 capsule

Phase 2

Carcinoma, Renal Cell

PF-07038124 ointment 0.01%

Phase 2

Atopic Dermatitis

SKI-606 (Bosutinib)

Phase 2

Chronic Myelogenous Leukemia

Lorlatinib

Phase 2

Carcinoma, Non-Small-Cell Lung

Methotrexate plus ERB-041 for 12 weeks

Phase 2

Rheumatoid Arthritis

AN2728 Topical Ointment, 2% QD

Phase 2

Dermatitis, Atopic

MRE0094

Phase 2

Foot Ulcer, Diabetic

Crisaborole ointment 2%

Phase 2

Atopic Dermatitis

852A

Phase 2

Melanoma

Tofacitinib ointment 20mg/g

Phase 2

Dermatitis, Atopic

PD 0200390

Phase 2

Nonrestorative Sleep

Ezetimibe

Phase 2

Hypercholesterolemia

vepdegestrant

Phase 2

Breast Cancer

PF-04236921

Phase 2

Crohn's Disease

cyclophosphamide

Phase 2

Peripheral T-cell Lymphoma

PF-06700841 15 mg

Phase 2

Systemic Lupus Erythematosus

Ponezumab

Phase 2

Cerebral Amyloid Angiopathy

HSP-130

Phase 2

Non-metastatic Breast Cancer

CP-547,632

Phase 2

Ovarian Neoplasms

Tisotumab vedotin (HuMax-TF-ADC)

Phase 2

Ovary Cancer

Anrukinzumab

Phase 2

Colitis, Ulcerative

PD-0332991

Phase 2

Neoplasms

tacrolimus

Phase 2

Kidney Transplantation

PH-797804

Phase 2

Pulmonary Disease, Chronic Obstructive

Esreboxetine

Phase 2

Fibromyalgia

AN2690, 2.5%

Phase 2

Distal, Subungual Onychomycosis

SU014813

Phase 2

Breast Neoplasms

Tdap

Phase 2

Pneumococcal Infections

PF-07868489

Phase 2

Pulmonary Arterial Hypertension

rLP2086 + MCV4 + Tdap

Phase 2

Vaccines

Meningococcal C

Phase 2

Meningitis, Meningococcal

PD 0348292

Phase 2

Venous Thrombosis

exemestane (Aromasin®)

Phase 2

Breast Neoplasms

SS-RBX

Phase 2

Urinary Incontinence, Stress

Bicalutamide

Phase 2

Prostate Cancer

bapineuzumab

Phase 2

Alzheimer Disease

Sunitinib Malate Continuous Daily Dosing

Phase 2

Carcinoma, Renal Cell

PF-06835919 Low Dose

Phase 2

Non-alcoholic Fatty Liver Disease

NXL104/ceftazidime

Phase 2

Complicated Urinary Tract Infection

Elranatamab (PF-06863135)

Phase 2

Multiple Myeloma

Staphylococcus aureus 4-antigen vaccine

Phase 2

Staphylococcal Infections

Anti-Beta Interferon (PF-06823859)

Phase 2

Dermatomyositis

ibuprofen

Phase 2

Pain

Doxycycline

Phase 2

Non Small Cell Lung Cancer (NSCLC)

PF-07220060 + PF-07104091 combination dose escalation

Phase 2

Breast Cancer

EXC 001

Phase 2

Scar Prevention

SAM-531

Phase 2

Alzheimer Disease

Sertraline and Elzasonan Combination

Phase 2

Depressive Disorder, Major

IMA-638

Phase 2

Asthma

PF-07976016

Phase 2

Obesity

SCA-136 (200 mg)

Phase 2

Schizophrenia

CP-778,875

Phase 2

Dyslipidemia

rLP2086 and Gardasil

Phase 2

Vaccines

CP-533, 536

Phase 2

Tibial Fractures

SBI-087

Phase 2

Active Rheumatoid Arthritis

60 mg/kg azithromycin ER

Phase 2

Acute Otitis Media

PF-04494700 - Low Dose Arm

Phase 2

Alzheimer Disease

CP-751, 871

Phase 2

Colorectal Neoplasm

PF-610,355

Phase 2

Asthma

rhBMP-2/CPM

Phase 2

Fractures

PF-04360365 10 mg/kg

Phase 2

Alzheimer's Disease

CE-224,535

Phase 2

Arthritis, Rheumatoid

BNT162b2 (Omi XBB.1.5)/RIV

Phase 2

Influenza, Human

Tamsulosin

Phase 2

Prostatic Hyperplasia

MultiStem low dose

Phase 2

Colitis, Ulcerative

PF-06882961 (Cohorts 1 and 2)

Phase 2

Obesity

PF-05221304

Phase 2

Nonalcoholic Fatty Liver Disease

PF-06801591

Phase 2

Advanced Malignancies

ARRY-520, KSP(Eg5) inhibitor; intravenous

Phase 2

Multiple Myeloma

SPK-9001

Phase 2

Hemophilia B

CP-866,087

Phase 2

Alcoholism

IMA-638 is a biologic

Phase 2

Asthma

CPG 7909

Phase 2

Carcinoma, Non-Small Cell Lung

FOLFIRI (Irinotecan, leucovorin, 5-fluorouracil [5FU])

Phase 2

Colorectal Neoplasms

ARRY-371797, p38 inhibitor; oral

Phase 2

LMNA-Related Dilated Cardiomyopathy

PF-07220060 CDK4 inhibitor

Phase 2

Advanced or Metastatic Breast Cancer

CP-751,871

Phase 2

Prostatic Neoplasms

CPG10101

Phase 2

Hepatitis, Chronic Active

PF-06372865

Phase 2

Chronic Low Back Pain

SU-011,248

Phase 2

Kidney Neoplasms

TMI-005

Phase 2

Rheumatoid Arthritis

RSV Vaccine

Phase 2

Respiratory Tract Infection

Pediatric HAV vaccine

Phase 2

Meningococcal B Disease

Peg-Intron

Phase 2

Hepatitis C

PF-06700841

Phase 2

Psoriatic Arthritis

Filanesib, KSP (Eg5) inhibitor; intravenous

Phase 2

Advanced Multiple Myeloma

dalteparin

Phase 2

Venous Thromboembolism

BAT

Phase 2

Gram-negative Bacterial Infections

PG4

Phase 2

Pneumococcal Disease

UK-369,003

Phase 2

Prostatic Hyperplasia

Dacomitinib

Phase 2

Non-small Cell Lung Cancer

PF-00232798

Phase 2

HIV

SB-525 (PF-07055480)

Phase 2

Hemophilia A

PF-07817883

Phase 2

SARS-CoV-2 Infection

PF-04634817

Phase 2

Diabetic Nephropathy

Influenza ModRNA Vaccine

Phase 2

Influenza, Human

ACC-001 + QS-21

Phase 2

Alzheimer Disease

Group B streptoccous 6-valent polysaccharide conjugate vaccine (GBS6)

Phase 2

Group B Streptococcal Infections

PELITREXOL/AG-2037

Phase 2

Colorectal Neoplasms

rhBMP-2/CPM injection and bisphosphonates, calcium, and vitamin D (oral bisphosphonate therapy)

Phase 2

Osteoporosis

Naproxen + PH-797804

Phase 2

Osteoarthritis

PF-3512676 + Erlotinib

Phase 2

Carcinoma, Non-Small-Cell Lung

Low Dose PF-07328948

Phase 2

Heart Failure

SU011248 (sunitinib)

Phase 2

Carcinoma, Renal Cell Metastasis

meningococcal B rLP2086 vaccine.

Phase 2

Meningitis, Meningococcal

PF-04136309

Phase 2

Osteoarthritis, Knee

Rapamune® (Sirolimus)

Phase 2

Kidney Transplantation

PF-04236921 SC injection

Phase 2

Crohn's Disease

Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)

Phase 2

Depression

SD-6010

Phase 2

Osteoarthritis

CP-690,550 Ointment 1

Phase 2

Psoriasis

AN2690

Phase 2

Onychomycosis

PF-00299804

Phase 2

Carcinoma, Non Small Cell Lung

lecozotan SR

Phase 2

Alzheimer Disease

PF-04383119 (tanezumab)

Phase 2

Osteoarthritis, Knee

BYL719

Phase 2

Colorectal Cancer

MYO-029

Phase 2

Becker Muscular Dystrophy

Vaccine

Phase 2

Meningococcal Vaccine

ACC-001 3 μg/ QS-21 50 μg

Phase 2

Alzheimer's Disease

azithromycin immediate release (Zithromax)

Phase 2

Pharmacokinetics

SRA-333

Phase 2

Alzheimer's Disease

CI-1040

Phase 2

Colorectal Neoplasms

PF-04171327 10 mg

Phase 2

Rheumatoid Arthritis

AN2728 Ointment Vehicle

Phase 2

Psoriasis

Tolterodine & Pregabalin

Phase 2

Overactive Bladder

Ceftazidime -avibactam

Phase 2

Complicated Urinary Tract Infections

PF-04950615 (RN316)

Phase 2

Hypercholesterolemia

PF-00592379

Phase 2

Impotence

PF-04360365 0.1 mg/kg

Phase 2

Alzheimer's Disease

Sunitinib malate (SU011248)

Phase 2

Gastrointestinal Stromal Tumors

PF-04383119 (RN624)

Phase 2

Low Back Pain

Lorazepam

Phase 2

Reflex Epilepsy, Photosensitive

UK-453,061

Phase 2

HIV-1

CP-690-550

Phase 2

Arthritis, Rheumatoid

NMDA Antagonist, CP-101,606 (traxoprodil)

Phase 2

Depressive Disorder, Major

pregabalin/PF-00489791

Phase 2

Postherpetic Neuralgia

sulopenem and PF-03709270

Phase 2

Pneumonia, Bacterial

UK0369,003

Phase 2

Impotence

PF-08049820

Phase 2

Atopic Dermatitis

Letrozole / Temsirolimus (CCI-779)

Phase 2

Breast Neoplasms

PF-04449913

Phase 2

Acute Myeloid Leukemia

Sunitinib (SU011248)

Phase 2

Liver Neoplasms

PF-00446687

Phase 2

Erectile Dysfunction

Celecoxib + Exemestane

Phase 2

Breast Neoplasms

ERB-041

Phase 2

Endometriosis

PD 0332334

Phase 2

Generalized Anxiety Disorder

Crisaborole ointment 2% BID

Phase 2

Dermatitis, Atopic

AG-013736 (Axitinib)

Phase 2

Acute Myeloid Leukemia (AML)

tacedinaline

Phase 2

Pancreatic Cancer

LEE011

Phase 2

Locally Advanced or Metastatic NRAS Mutant Melanoma

150 mg PF-04991532

Phase 2

Diabetes, Type 2

inotuzumab ozogamicin (CMC-544)

Phase 2

Lymphoma, B-Cell

ceftazidime/NXL104 + metronidazole

Phase 2

Complicated Intra-abdominal Infections

PF-04494700

Phase 2

Alzheimer's Disease

CCI-779

Phase 2

Multiple Sclerosis, Relapsing-Remitting

sunitinib malate dose escalation

Phase 2

Gastrointestinal Stromal Tumors

CP-690,550 Eye drops

Phase 2

Dry Eye Syndromes

Meropenem

Phase 2

Complicated Intra-abdominal Infections

Tofimilast

Phase 2

Asthma

PF-03654746

Phase 2

Excessive Daytime Sleepiness

PF-00734200 10 mg QD

Phase 2

Diabetes Mellitus, Type 2

Tick-borne Encephalitis Vaccine

Phase 2

Tick-borne Encephalitis

PF-02545920

Phase 2

Huntington's Disease

Sumatriptan

Phase 2

Migraine

25 mg PF-04991532

Phase 2

Diabetes Mellitus, Type 2

PF-00217830

Phase 2

Schizophrenia

Ibuprofen/acetaminophen

Phase 2

Pain

EKB-569

Phase 2

Colorectal Neoplasms

PF-06835375

Phase 2

Primary Immune Thrombocytopenia

MAC-321

Phase 2

Colorectal Neoplasms

CP-690,550 + methotrexate

Phase 2

Rheumatoid Arthritis

Torisel

Phase 2

Adenocarcinoma

PF-06463922

Phase 2

ALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLC

Dexmedetomidine, midazolam; fentanyl

Phase 2

Intubated and Mechanically Ventilated Pediatric Subjects

CP- 690 550

Phase 2

Ulcerative Colitis

Vupanorsen

Phase 2

Dyslipidemias

PF-04191834

Phase 2

Asthma

PF-04171327

Phase 2

Rheumatoid Arthritis

C. difficile vaccine (previously studied formulation).

Phase 2

Clostridoides Difficile Associated Disease

Risperidone

Phase 2

Schizophrenia

Kaletra

Phase 2

HIV Infections

PF-06865571

Phase 2

Nonalcoholic Steatohepatitis

Anti-NGF AB

Phase 2

Neoplasms

EXC 001 (currently called PF-06473871)

Phase 2

Reduction in Severity of Skin Scarring

Carfilzomib, proteasome inhibitor; intravenous

Phase 2

Advanced Multiple Myeloma

active comparator

Phase 2

Pulmonary Disease, Chronic Obstructive

PF-06835919

Phase 2

Non-alcoholic Steatohepatitis

Tygacil

Phase 2

Bacterial Infections

(Part C) MET097

Phase 2

Obesity and Overweight

ILV-094

Phase 2

Rheumatoid Arthritis

CE-326,597 100 mg QD

Phase 2

Weight Management

CI-1033

Phase 2

Breast Neoplasms

ALO-01

Phase 2

Healthy

PF-06650833

Phase 2

Acne Inversa

Capravirine

Phase 2

Human Immunodeficiency Virus

Bivalent rLP2086 Vaccine

Phase 2

MENINGOCOCCAL INFECTION

PF-04494700 (TTP488)

Phase 2

Diabetic Nephropathy

Celecoxib, COX-2 inhibitor; oral

Phase 2

Dental Pain

Repevax

Phase 2

Meningococcal Vaccine

CI 1033

Phase 2

Lung Neoplasms

Ritlecitinib 50 mg

Phase 2

Chronic Spontaneous Urticaria

mPnC candidate

Phase 2

Healthy Participants

QS-21

Phase 2

Alzheimer Disease

Part A: ATM-AVI Single Dose, Cohorts 1-4

Phase 2

Gram-negative Bacterial Infection

mIRV

Phase 2

Influenza, Human

Open

Phase 2

Chronic Kidney Disease

Leuprolide

Phase 2

Prostate Cancer

vabicaserin

Phase 2

Schizophrenia

Crizotinib

Phase 2

Non Small Cell Lung Cancer

PF-04937319 - 3mg

Phase 2

Type 2 Diabetes Mellitus

Bortezomib

Phase 2

Multiple Myeloma

Atomoxetine

Phase 2

Attention Deficit Disorder With Hyperactivity

AN2690, 5%

Phase 2

Distal, Subungual Onychomycosis

RN624 (PF-04383119)

Phase 2

Osteoarthritis

PF-3512676

Phase 2

Lymphoma, T-Cell, Cutaneous

Gefitinib + Sunitinib

Phase 2

Carcinoma, Renal Cell

BGJ398

Phase 2

Melanoma

Tanezumab 10 mg IV

Phase 2

Neoplasm Metastasis

Regulatory & News

Approvals, filings, and latest developments

Regulatory Approvals
PFE News